(Q39376100)

11 September 2017

1 reference

title

From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases (English)

1 reference

Karolina Skonieczna-Żydecka

11 September 2017

0 references

object named as

Karolina Skonieczna-Żydecka

series ordinal

3

0 references

Wojciech Marlicz

series ordinal

1

object named as

Wojciech Marlicz

1 reference

11 September 2017

2

Diana E Yung

1 reference

11 September 2017

Anastasios Koulaouzidis

series ordinal

7

object named as

Anastasios Koulaouzidis

1 reference

11 September 2017

4

Igor Loniewski

1 reference

11 September 2017

6

Beata Loniewska

1 reference

11 September 2017

Saskia van Hemert

5

1 reference

11 September 2017

publication date

16 June 2017

1 reference

Expert Review of Gastroenterology & Hepatology

11 September 2017

published in

1 reference

11 September 2017

page(s)

1-18

1 reference

Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

NSAID enteropathy and bacteria: a complicated relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Anatomy and Physiology of the Small Bowel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The intestinal epithelial barrier: a therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A gut-vascular barrier controls the systemic dissemination of bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Human Intestinal Barrier Function in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Flavivirus NS5 associates with host-cell proteins zonula occludens-1 (ZO-1) and regulating synaptic membrane exocytosis-2 (RIMS2) via an internal PDZ binding mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Involvement of claudin-7 in HIV infection of CD4(-) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Junction adhesion molecule is a receptor for reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Expression of rotavirus NSP4 alters the actin network organization through the actin remodeling protein cofilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A nuclear factor-κB signaling pathway via protein kinase C δ regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

On the interaction of Clostridium perfringens enterotoxin with claudins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Enteroaggregative Escherichia coli Disrupts Epithelial Cell Tight Junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

TNFalpha up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Redistribution of tight junction proteins during EPEC infection in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Enteropathogenic Escherichia coli, Shigella flexneri, and Listeria monocytogenes recruit a junctional protein, zonula occludens-1, to actin tails and pedestals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Shigella targets epithelial tricellular junctions and uses a noncanonical clathrin-dependent endocytic pathway to spread between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Maturation of mucosal immune responses and influence of maternal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Small intestine and microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

High temporal and inter-individual variation detected in the human ileal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Human gut microbiome adopts an alternative state following small bowel transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The small intestine microbiota, nutritional modulation and relevance for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Microbiota of the Small Intestine Is Selectively Engulfed by Phagocytes of the Lamina Propria and Peyer's Patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Tight junction pore and leak pathways: a dynamic duo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Experimental Models of Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Tricellulin forms homomeric and heteromeric tight junctional complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Loss of occludin affects tricellular localization of tricellulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

DNA methylation is required for the control of stem cell differentiation in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Dendritic cells in intestinal homeostasis and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Multi-faceted functions of secretory IgA at mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Microbial learning lessons: SFB educate the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Intestinal permeability--a new target for disease prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Intestinal permeation and gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Evaluation of a triple sugar test of colonic permeability in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Novel multi-sugar assay for site-specific gastrointestinal permeability analysis: a randomized controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Intestinal permeability in patients with adverse reactions to food

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Non-invasive assessment of barrier integrity and function of the human gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A high-fat diet is associated with endotoxemia that originates from the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Biomarkers in Search of Precision Medicine in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Diversity of human small intestinal Streptococcus and Veillonella populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A novel ingestible electronic drug delivery and monitoring device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Classification of functional bowel disorders by objective physiological criteria based on endoluminal image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

New insight into intestinal motor function via noninvasive endoluminal image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

New objective evaluation method for functional bowel disorder using video capsule endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The Wireless Motility Capsule: a One-Stop Shop for the Evaluation of GI Motility Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Morpho-functional evaluation of small bowel using wireless motility capsule and video capsule endoscopy in patients with known or suspected Crohn's disease: pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Novel diagnostics and therapy of colonic motor disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Gastrointestinal transit in patients with systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Application and Efficacy of Super-Magnifying Endoscopy for the Lower Intestinal Tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Increased Epithelial Gap Density in the Noninflamed Duodenum of Children With Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Endoscopic imaging of parasites in the human digestive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Editorial: Moving Away From Focussing on Gastric Pathophysiology in Functional Dyspepsia: New Insights and Therapeutic Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Kyoto global consensus report on Helicobacter pylori gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Small Intestinal Bacterial Overgrowth: A Primary Care Review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Small intestinal bacterial overgrowth: what it is and what it is not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

21 January 2018

A Breath of Fresh Air.

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Immune-epithelial crosstalk at the intestinal surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Can probiotics modulate human disease by impacting intestinal barrier function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The impact of probiotics and prebiotics on the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Anchorless surface associated glycolytic enzymes from Lactobacillus plantarum 299v bind to epithelial cells and extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Nitric oxide in mucosal defense: a little goes a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Symbiotic bacteria direct expression of an intestinal bactericidal lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The role of the immune system in governing host-microbe interactions in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Mannose-specific interaction of Lactobacillus plantarum with porcine jejunal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Therapeutic potential of fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

European consensus conference on faecal microbiota transplantation in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Consensus report: faecal microbiota transfer - clinical applications and procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Mirror, mirror on the wall: which microbiomes will help heal them all?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

The dormant blood microbiome in chronic, inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Toward clinical genomics in everyday medicine: perspectives and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Fostering Collaboration Through Creation of an IBD Learning Health System

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Mo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Adhesive capability of Lactobacillus plantarum 299v is important for preventing bacterial translocation in endotoxemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2017.1343664

10.1080/17474124.2017.1343664

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference